Xerostomia and Clinical Outcomes in Definitive Intensity Modulated Radiotherapy (IMRT) Versus Three-dimensional Conformal Radiotherapy (3D-CRT) for Head and Neck Squamous Cell Carcinoma: A Meta-analysis.
DE Felice F, Pranno N, Papi P, Brugnoletti O, Tombolini V, Polimeni A.
In Vivo. 2020 Mar-Apr;34(2):623-629. doi: 10.21873/invivo.11816.
Three-dimensional conformal radiotherapy (3D-CRT) vs. volumetric modulated arc therapy (VMAT) in deep inspiration breath-hold (DIBH) technique in left-sided breast cancer patients-comparative analysis of dose distribution and estimation of projected secondary cancer risk.
Racka I, Majewska K, Winiecki J.
Strahlenther Onkol. 2023 Jan;199(1):90-101. doi: 10.1007/s00066-022-01979-2. Epub 2022 Aug 9.
Potential gains: Comparison of a mono-isocentric three-dimensional conformal radiotherapy (3D-CRT) planning technique to hybrid intensity-modulated radiotherapy (hIMRT) to the whole breast and supraclavicular fossa (SCF) region.
Ambrose L, Stanton C, Lewis L, Lamoury G, Morgia M, Carroll S, Bromley R, Atyeo J.
J Med Radiat Sci. 2022 Mar;69(1):75-84. doi: 10.1002/jmrs.473. Epub 2021 May 6.
3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
Zou LQ, Zhang BL, Chang Q, Zhu FP, Li YY, Wei YQ, Guan YS.
World J Gastroenterol. 2014 Dec 7;20(45):17227-34. doi: 10.3748/wjg.v20.i45.17227.
Comparison three-dimensional conformal radiotherapy versus intensity modulated radiation therapy in local control of head and neck cancer.
Ghosh G, Gupta G, Malviya A, Saroj D.
J Cancer Res Ther. 2018 Oct-Dec;14(6):1412-1417. doi: 10.4103/jcrt.JCRT_725_17.
Three-dimensional conformal radiotherapy in combination with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma.
Chen WJ, Yuan SF, Zhu LJ, Sun XN, Zheng W.
J BUON. 2014 Jul-Sep;19(3):692-7.
Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial.
Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, Murthy V, Budrukkar A, Dinshaw K, Prabhash K, Chaturvedi P, D'Cruz A.
Radiother Oncol. 2012 Sep;104(3):343-8. doi: 10.1016/j.radonc.2012.07.001. Epub 2012 Jul 30.
Pelvic Ewing sarcomas. Three-dimensional conformal vs. intensity-modulated radiotherapy.
Mounessi FS, Lehrich P, Haverkamp U, Willich N, Bölling T, Eich HT.
Strahlenther Onkol. 2013 Apr;189(4):308-14. doi: 10.1007/s00066-012-0304-z. Epub 2013 Feb 28.
Safety of Three-Dimensional Conformal Radiotherapy on the Sheep with Pulmonary Cystic Echinococcosis: A Preliminary Study.
Zhang Y, Lu P, Qi H, Mao R, Bao Y.
Acta Parasitol. 2024 Mar;69(1):559-566. doi: 10.1007/s11686-023-00751-5. Epub 2024 Jan 17.
Dosimetric comparison between three-dimensional conformal radiotherapy followed by electron beam boost and volumetric modulated arc therapy using concomitant boost for the heart and cardiac segments in patients with left-sided breast cancer at risk for radiation-induced cardiac toxicity.
Murakami Y, Murakami Y, Kamima T, Oguchi M, Abo N, Takahashi T, Kaneko M, Nakano M, Matsubayashi F, Harada A, Taguchi S, Hashimoto T, Yoshioka Y.
Phys Med. 2022 Mar;95:126-132. doi: 10.1016/j.ejmp.2022.02.003. Epub 2022 Feb 11.
